Overview

A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

Status:
Not yet recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of human TH-SC01 cell injection for the treatment of perianal fistulas in Crohn's Disease
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Collaborator:
Changhai Hospital